ClinicalTrials.Veeva

Menu

Clinical and Histological Evaluation of Hesperidin as a Direct Pulp Capping Material

Cairo University (CU) logo

Cairo University (CU)

Status

Completed

Conditions

Pulp Exposure, Dental
Dental Pulp Capping

Treatments

Other: Mineral Trioxide Aggregate (MTA)
Other: Hesperidin

Study type

Interventional

Funder types

Other

Identifiers

NCT06402032
Hesperidin_MTA

Details and patient eligibility

About

Direct pulp capping technique is one of the oldest known treatments for exposed pulp tissue, and there is a continuous requirement for the most efficient materials to be used in this approach. Successful pulp capping is the usual way to preserve the vitality of tooth and avoid root canal treatment or surgical tooth extraction.

Enrollment

32 patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Good oral hygiene,
  • Sound wisdom teeth with closed apices with normal pulp vitality response
  • No periodontal disease or periapical lesions on periapical radiograph
  • Cooperative patients approving to participate in the study

Exclusion criteria

  • Medically compromised participants
  • Evidence of parafunctional habits
  • Heavy smokers
  • Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis
  • Severe periodontal problems or pathological periapical changes
  • Teeth with open apex or pulp calcification

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

32 participants in 2 patient groups

Hesperidin
Experimental group
Treatment:
Other: Hesperidin
Mineral trioxide aggregate (MTA)
Active Comparator group
Treatment:
Other: Mineral Trioxide Aggregate (MTA)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems